Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.

De Pascale G, Montini L, Pennisi M, Bernini V, Maviglia R, Bello G, Spanu T, Tumbarello M, Antonelli M. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care. 2014 May 05; 18(3):R90.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.